Responses
Emerging Technologies, Pharmacology and Therapeutics
DPP4i, thiazolidinediones, or insulin and risks of cancer in patients with type 2 diabetes mellitus on metformin–sulfonylurea dual therapy with inadequate control
Compose a Response to This Article
Other responses
No responses have been published for this article.